Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-266,527
Closed -$16.2M 10
2017
Q1
$16.2M Hold
266,527
2.17% 7
2016
Q4
$15M Hold
266,527
2.12% 8
2016
Q3
$15.9M Buy
266,527
+12,261
+5% +$717K 2.17% 6
2016
Q2
$14M Hold
254,266
2.15% 6
2016
Q1
$12.8M Hold
254,266
2.11% 6
2015
Q4
$12.8M Buy
254,266
+3,144
+1% +$159K 2.15% 8
2015
Q3
$11.8M Buy
251,122
+17,816
+8% +$946K 2.19% 8
2015
Q2
$12.7M Hold
233,306
2.27% 5
2015
Q1
$12.8M Hold
233,306
2.21% 5
2014
Q4
$12.6M Buy
233,306
+208,154
+828% +$11.6M 1.98% 6
2014
Q3
$1.42M Buy
+25,152
New +$1.41M 0.27% 11

Other funds holding MRK

LJ Trust's MRK Position: Q2 2017 in Review

LJ Trust sold out of Merck (MRK) in Q2 2017, closing a stake of 266,527 shares — an estimated $16.2M sold.

LJ Trust first reported a position in MRK in Q3 2014 and held it in 11 quarters. The position peaked at $16.2M in Q1 2017. 1,926 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • LJ Trust reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
  • LJ Trust sold 266,527 Merck shares in Q2 2017, an estimated $16.2M.
  • LJ Trust first reported a position in Merck in Q3 2014 and held it in 11 quarters.
  • LJ Trust's Merck position peaked at $16.2M in Q1 2017.
  • 1,926 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on LJ Trust's 13F filing for Q2 2017.